Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-12-02 Sale | 2024-12-03 5:21 pm | Amylyx Pharmaceuticals Inc. | AMLX | Bedrosian Camille L Chief Medical Officer | 5,421 | $5.5354 | $30,007 | 138,380 (Direct) | View |
| 2024-09-30 Sale | 2024-10-02 6:50 pm | Amylyx Pharmaceuticals Inc. | AMLX | Bedrosian Camille L Chief Medical Officer | 11,442 | $3.1952 | $36,559 | 143,801 (Direct) | View |
| 2023-03-01 Sale | 2023-03-03 8:00 pm | Ultragenyx Pharmaceutical Inc. | RARE | Bedrosian Camille L EVP and Chief Medical Officer | 3,881 | $45.25 | $175,615 | 46,720 (Direct) | View |
| 2022-03-01 Sale | 2022-03-03 6:07 pm | Ultragenyx Pharmaceutical Inc. | RARE | Bedrosian Camille L EVP and Chief Medical Officer | 2,821 | $66.62 | $187,935 | 72,838 (Direct) | View |
| 2022-01-30 Sale | 2022-02-01 1:39 pm | Ultragenyx Pharmaceutical Inc. | RARE | Bedrosian Camille L EVP and Chief Medical Officer | 1,657 | $66.3 | $109,859 | 36,759 (Direct) | View |
| 2021-10-14 Sale | 2021-10-18 7:02 pm | Ultragenyx Pharmaceutical Inc. | RARE | Bedrosian Camille L EVP and Chief Medical Officer | 359 | $81.14 | $29,129 | 38,416 (Direct) | View |
| 2021-09-01 Sale | 2021-09-02 6:11 pm | Ultragenyx Pharmaceutical Inc. | RARE | Bedrosian Camille L EVP and Chief Medical Officer | 5,000 | $100.11 | $500,525 | 147,275 (Direct) | View |
| 2021-05-06 Sale | 2021-05-10 6:09 pm | Ultragenyx Pharmaceutical Inc. | RARE | Bedrosian Camille L EVP and Chief Medical Officer | 364 | $113.67 | $41,376 | 38,775 (Direct) | View |
| 2021-04-15 Sale | 2021-04-19 5:17 pm | Ultragenyx Pharmaceutical Inc. | RARE | Bedrosian Camille L EVP and Chief Medical Officer | 5,000 | $109.09 | $545,450 | 97,139 (Direct) | View |
| 2021-03-01 Sale | 2021-03-03 8:37 pm | Ultragenyx Pharmaceutical Inc. | RARE | Bedrosian Camille L EVP and Chief Medical Officer | 4,543 | $138.18 | $627,752 | 50,139 (Direct) | View |
| 2021-01-30 Sale | 2021-02-02 4:28 pm | Ultragenyx Pharmaceutical Inc. | RARE | Bedrosian Camille L EVP and Chief Medical Officer | 2,243 | $140.36 | $314,827 | 33,546 (Direct) | View |
| 2021-01-15 Sale | 2021-01-19 4:01 pm | Ultragenyx Pharmaceutical Inc. | RARE | Bedrosian Camille L EVP and Chief Medical Officer | 25,000 | $139.18 | $3,479,500 | 98,789 (Direct) | View |
| 2020-10-14 Sale | 2020-10-16 7:22 pm | Ultragenyx Pharmaceutical Inc. | RARE | Bedrosian Camille L EVP and Chief Medical Officer | 262 | $88 | $23,056 | 35,789 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-06-21 Exercise | 2024-06-25 4:37 pm | N/A N/A | RHYTHM PHARMACEUTICALS INC. | RYTM | Bedrosian Camille L Director | 3,000 | $0 | 3,000 (Direct) | View |
| 2024-06-18 Option Award | 2024-06-20 9:41 pm | N/A 2034-06-17 | RHYTHM PHARMACEUTICALS INC. | RYTM | Bedrosian Camille L Director | 18,000 | $0 | 18,000 (Direct) | View |
| 2024-06-07 Option Award | 2024-06-11 4:19 pm | N/A 2034-06-07 | Crinetics Pharmaceuticals Inc. | CRNX | Bedrosian Camille L Director | 15,900 | $0 | 21,900 (Direct) | View |
| 2024-04-16 Option Award | 2024-04-18 8:19 pm | N/A 2034-04-15 | Amylyx Pharmaceuticals Inc. | AMLX | Bedrosian Camille L Chief Medical Officer | 216,910 | $0 | 275,243 (Direct) | View |
| 2023-11-27 Option Award | 2023-11-29 4:49 pm | N/A 2033-11-26 | Amylyx Pharmaceuticals Inc. | AMLX | Bedrosian Camille L Chief Medical Officer | 220,833 | $0 | 220,833 (Direct) | View |
| 2023-06-21 Option Award | 2023-06-23 4:30 pm | N/A 2033-06-20 | RHYTHM PHARMACEUTICALS INC. | RYTM | Bedrosian Camille L Director | 17,000 | $0 | 17,000 (Direct) | View |
| 2023-06-16 Option Award | 2023-06-21 5:00 pm | N/A 2033-06-15 | Crinetics Pharmaceuticals Inc. | CRNX | Bedrosian Camille L Director | 23,500 | $0 | 23,500 (Direct) | View |
| 2023-03-01 Option Award | 2023-03-03 8:00 pm | N/A N/A | Ultragenyx Pharmaceutical Inc. | RARE | Bedrosian Camille L EVP and Chief Medical Officer | 2,663 | $0 | 46,720 (Direct) | View |
| 2022-06-17 Option Award | 2022-06-21 4:44 pm | N/A 2032-06-16 | Crinetics Pharmaceuticals Inc. | CRNX | Bedrosian Camille L Director | 17,500 | $0 | 17,500 (Direct) | View |
| 2022-06-08 Option Award | 2022-06-10 4:09 pm | N/A 2032-06-07 | RHYTHM PHARMACEUTICALS INC. | RYTM | Bedrosian Camille L Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2022-03-01 Option Award | 2022-03-03 6:07 pm | N/A 2032-03-01 | Ultragenyx Pharmaceutical Inc. | RARE | Bedrosian Camille L EVP and Chief Medical Officer | 38,900 | $0 | 72,838 (Direct) | View |
| 2021-09-01 Exercise | 2021-09-02 6:11 pm | N/A 2028-01-30 | Ultragenyx Pharmaceutical Inc. | RARE | Bedrosian Camille L EVP and Chief Medical Officer | 5,000 | $0 | 147,275 (Direct) | View |
| 2021-09-01 Exercise | 2021-09-02 6:11 pm | N/A N/A | Ultragenyx Pharmaceutical Inc. | RARE | Bedrosian Camille L EVP and Chief Medical Officer | 5,000 | $55 | 147,275 (Direct) | View |
| 2021-06-22 Option Award | 2021-06-23 5:00 pm | N/A 2031-06-21 | Crinetics Pharmaceuticals Inc. | CRNX | Bedrosian Camille L Director | 17,500 | $0 | 17,500 (Direct) | View |
| 2021-06-09 Option Award | 2021-06-11 4:05 pm | N/A 2031-06-08 | RHYTHM PHARMACEUTICALS INC. | RYTM | Bedrosian Camille L Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2021-04-15 Exercise | 2021-04-19 5:17 pm | N/A 2028-01-30 | Ultragenyx Pharmaceutical Inc. | RARE | Bedrosian Camille L EVP and Chief Medical Officer | 5,000 | $0 | 97,139 (Direct) | View |
| 2021-04-15 Exercise | 2021-04-19 5:17 pm | N/A N/A | Ultragenyx Pharmaceutical Inc. | RARE | Bedrosian Camille L EVP and Chief Medical Officer | 5,000 | $55 | 97,139 (Direct) | View |
| 2021-03-01 Option Award | 2021-03-03 8:37 pm | N/A 2031-03-01 | Ultragenyx Pharmaceutical Inc. | RARE | Bedrosian Camille L EVP and Chief Medical Officer | 21,136 | $0 | 50,139 (Direct) | View |
| 2021-01-15 Exercise | 2021-01-19 4:01 pm | N/A 2028-01-30 | Ultragenyx Pharmaceutical Inc. | RARE | Bedrosian Camille L EVP and Chief Medical Officer | 25,000 | $0 | 98,789 (Direct) | View |
| 2021-01-15 Exercise | 2021-01-19 4:01 pm | N/A N/A | Ultragenyx Pharmaceutical Inc. | RARE | Bedrosian Camille L EVP and Chief Medical Officer | 25,000 | $55 | 98,789 (Direct) | View |
| 2020-12-09 Option Award | 2020-12-11 4:11 pm | N/A 2030-12-08 | RHYTHM PHARMACEUTICALS INC. | RYTM | Bedrosian Camille L Director | 37,000 | $0 | 37,000 (Direct) | View |
| 2020-09-01 Option Award | 2020-09-03 5:58 pm | N/A 2030-08-31 | Crinetics Pharmaceuticals Inc. | CRNX | Bedrosian Camille L Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2020-05-06 Tax Withholding | 2020-05-08 8:12 pm | N/A N/A | Ultragenyx Pharmaceutical Inc. | RARE | Bedrosian Camille L EVP and Chief Medical Officer | 249 | $66.26 | 36,051 (Direct) | View |
| 2020-03-01 Tax Withholding | 2020-03-03 7:45 pm | N/A N/A | Ultragenyx Pharmaceutical Inc. | RARE | Bedrosian Camille L EVP and Chief Medical Officer | 1,249 | $56.08 | 57,300 (Direct) | View |
| 2020-03-01 Option Award | 2020-03-03 7:45 pm | N/A 2030-03-01 | Ultragenyx Pharmaceutical Inc. | RARE | Bedrosian Camille L EVP and Chief Medical Officer | 33,934 | $0 | 57,300 (Direct) | View |
| 2020-01-30 Tax Withholding | 2020-01-31 1:58 pm | N/A N/A | Ultragenyx Pharmaceutical Inc. | RARE | Bedrosian Camille L EVP and Chief Medical Officer | 1,624 | $53.23 | 24,615 (Direct) | View |